Galencia's Bid For Relypsa Is 'Reasonable,' Another Bidder 'Unlikely'

By: via Benzinga
Swiss healthcare group Galenica has agreed to acquire Relypsa Inc (NASDAQ: RLYP) for $1.53 billion. Relypsa received two downgrades ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.